- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07247916
Developing and Piloting an Implementation Strategy for a Brief, Motivational Interviewing-based Lethal Means Safety Counseling Intervention in Primary Care Settings (CDA-2)
November 20, 2025 updated by: VA Office of Research and Development
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury.
Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms.
However, no LMS counseling interventions have been tested within VA.
Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Steve Martino, PhD
- Phone Number: 2468 (203) 932-5711
- Email: Steve.Martino@va.gov
Study Contact Backup
- Name: Frances Aunon, PhD MS
- Phone Number: 7894 (203) 932-5711
- Email: Frances.Aunon@va.gov
Study Locations
-
-
Connecticut
-
West Haven, Connecticut, United States, 06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contact:
- Steve Martino, PhD
- Phone Number: 2468 (203) 932-5711
- Email: Steve.Martino@va.gov
-
Contact:
- Kimberly L Selander, MA
- Phone Number: 203-932-5711
- Email: Kimberly.Selander@va.gov
-
Principal Investigator:
- Frances Aunon, PhD MS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
For Veterans:
- Has access to a firearm
- Referred to PCMHI care
For clinicians (delivering intervention):
- deliver care in PCMHI
- trained in RAMP and study procedures
Exclusion Criteria:
For Veterans:
- Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
- Unreliable telephone access
- Inability to read English or communicate in spoken and written English
For clinicians (delivering intervention):
- Did not participate in training
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active control
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the PCMHI clinician.
This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource.
This condition will control for time and attention, subject matter, mode of delivery, and setting.
|
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the PCMHI clinician.
This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource.
This condition will control for time and attention, subject matter, mode of delivery, and setting.
|
|
Experimental: RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care.
RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage
|
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care.
RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screening
Time Frame: through study completion, approximately 2 years
|
Investigators will assess the number of new PCMHI patients seen in PCMHI and the number who were approached about potential study participation per month
|
through study completion, approximately 2 years
|
|
Recruitment
Time Frame: through study completion, approximately 2 years
|
Investigators will track the number of eligible Veterans who enrolled in the study per month
|
through study completion, approximately 2 years
|
|
Retention
Time Frame: approximately 30 days
|
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments.
|
approximately 30 days
|
|
Assessment of behavioral outcomes
Time Frame: approximately 30 days
|
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint
|
approximately 30 days
|
|
Veteran acceptability - Theoretical Framework of Acceptability
Time Frame: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention.
Each item has 5 answer options (1-5) on a Likert Scale.
Score range is 8 to 40, with a higher score indicating more higher reported acceptability.
|
At immediate follow up, within approximately 2 weeks of intervention
|
|
Veteran acceptability - Experience and Satisfaction with intervention
Time Frame: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention.
|
At immediate follow up, within approximately 2 weeks of intervention
|
|
Clinician acceptability - Theoretical Framework of Acceptability
Time Frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention.
Each item has 5 answer options (1-5) on a Likert Scale.
Score range is 8 to 40, with a higher score indicating more higher reported acceptability.
|
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
|
Clinician acceptability - Negative impact
Time Frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will assess to what extent PCMHI clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree."
For those responding >3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration).
|
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Frances Aunon, PhD MS, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2027
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
December 31, 2031
Study Registration Dates
First Submitted
November 14, 2025
First Submitted That Met QC Criteria
November 20, 2025
First Posted (Actual)
November 25, 2025
Study Record Updates
Last Update Posted (Actual)
November 25, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSR4-001-24W
- 1IK2RD000503-01A2%9 (Other Grant/Funding Number: VA Office of Research & Development)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide Prevention
-
Mental Health Services in the Capital Region, DenmarkKarolinska InstitutetCompleted
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
-
University of North Carolina, Chapel HillVillage Heartbeat, Inc.RecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
George Washington UniversityUniversity of Rochester; Mt. Sinai School of Medicine, New York, New York; American...Recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
Yale UniversityNational Institute of Mental Health (NIMH); PossibleRecruiting
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Robert Wood Johnson FoundationRecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
University of MichiganNational Institute of Mental Health (NIMH); Children's Hospital of Michigan; ...RecruitingBehavioral Symptoms | Suicide | Self-Injurious Behavior | Behavior | Suicide PreventionUnited States
Clinical Trials on Active control
-
Shanghai SIMR Biotechnology Co., Ltd.CompletedPeripheral Neuropathic PainAustralia
-
Vanda PharmaceuticalsCompleted
-
George Mason UniversityNational Endowment for the Arts, United StatesCompletedQuality of Life | Physical Activity | Cognitive Impairment | Self-Perception | Social Isolation | Mental Status ChangeUnited States
-
University of RochesterCompleted
-
Federal University of Health Science of Porto AlegreCompleted
-
BeHnam KhodaRahmiNot yet recruitingStress Regulation and Well-being in Non-clinical ContextsUnited Kingdom
-
Hungarian University of Sports ScienceSemmelweis UniversityActive, not recruiting
-
University of California, San DiegoNational Institute of Mental Health (NIMH); University of Miami; The University...RecruitingSchizoaffective Disorder | Psychotic Disorder | Schizophrenia DisordersUnited States
-
University Medical Center GroningenCompletedEsophageal Cancer | Lung CancerNetherlands